A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Sep 2003
- 838-45 p. digital